1. Home
  2. ATEN vs WVE Comparison

ATEN vs WVE Comparison

Compare ATEN & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo A10 Networks Inc.

ATEN

A10 Networks Inc.

HOLD

Current Price

$18.19

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$16.01

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATEN
WVE
Founded
2004
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
ATEN
WVE
Price
$18.19
$16.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
15
Target Price
$21.50
$27.53
AVG Volume (30 Days)
684.1K
12.9M
Earning Date
11-04-2025
11-10-2025
Dividend Yield
1.32%
N/A
EPS Growth
4.68
N/A
EPS
0.69
N/A
Revenue
$284,406,000.00
$109,230,000.00
Revenue This Year
$12.37
N/A
Revenue Next Year
$8.10
$31.09
P/E Ratio
$26.31
N/A
Revenue Growth
10.27
103.75
52 Week Low
$13.81
$5.28
52 Week High
$21.90
$21.73

Technical Indicators

Market Signals
Indicator
ATEN
WVE
Relative Strength Index (RSI) 61.28 65.75
Support Level $17.76 $6.93
Resistance Level $18.65 $21.73
Average True Range (ATR) 0.33 1.51
MACD 0.16 1.14
Stochastic Oscillator 77.47 61.45

Price Performance

Historical Comparison
ATEN
WVE

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: